LuciPral is used in RET fusion-positive lung and thyroid
cancers. It is a targeted therapy used globally.
Active Ingredient
Pralsetinib inhibits RET kinase activity.
Uses of LuciPral
• RET-positive NSCLC
• Thyroid cancer
How LuciPral Works
Blocks RET signaling pathways involved in tumor growth.
How to Use LuciPral
• Take on empty stomach
Possible Side Effects
• Hypertension
• Fatigue
Precautions
• Monitor blood pressure
Safety Information
Use under supervision.
Storage
• Store at room temperature
• Protect from moisture and sunlight
• Keep out of reach of children